Epysqli Injection, Solution
Product Images NDC 51759-208

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Epysqli (NDC 51759-208). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (30 mL Vial Label)

Label for EPYSQLI injection, an intravenous solution containing eculizumab-aagh at 300 mg/30 mL (10 mg/mL). The single-dose vial label states no preservatives, storage refrigerated at 2°C to 8°C, with instructions to protect from light, not freeze, and not shake. Manufactured for Teva Pharmaceuticals USA, Inc. by Samsung Bioepis Co., Ltd. Includes barcode and spaces for lot and expiration dates.*

FDA Label Image

Principal Display Panel (30 mL Vial Carton)

Packaging label for EPYSQLI (eculizumab-aagh) Injection 300 mg/30 mL (10 mg/mL) by Teva Pharmaceuticals USA, Inc. This label is for a single-dose vial injection solution for intravenous infusion. The label includes dosage strength, storage instructions, ingredient details, barcode, and manufacturer information including Samsung Bioepis as a co-manufacturer. It specifies no preservatives and mentions the requirement for dilution before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.